Copegus is used to treat chronic hepatitis C virus infections. It acts as an antiviral, helping to reduce viral replication within the body. It is often used in conjunction with other medications, such as interferon, to achieve better therapeutic outcomes. Copegus is unique in that it directly targets the virus, contributing to a reduction in viral load and a gradual improvement in liver function. This helps reduce the risk of the disease progressing to advanced stages, such as cirrhosis or liver failure.
Copegus helps strengthen the body's immune response against viruses by affecting the virus's genetic material, thus preventing its spread and increasing the chances of its effective elimination. This makes it an important drug in chronic hepatitis C treatment plans. Therefore, it must be used under medical supervision and with ongoing monitoring to analyze liver function, ensuring maximum benefit while minimizing any side effects that may occur during treatment.